Infectious Disease
Infectious Disease(传染病)
Infectious Disease 相关产品(1138)
- GC43825Histone H1-derived Peptide (trifluoroacetate salt)纯度: >95.00%
A peptide substrate for CRK3/CYC6
- GC44050Leucinostatin ACAS: 76600-38-9纯度: >95.00%
A fungal metabolite with diverse biological activities
- GC44101Lyso-Globotriaosylceramide (d18:1)CAS: 126550-86-5纯度: >98.00%
A globotriaosylceramide lacking the fatty acyl group
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43824 | Hirsutide | 865368-30-5 | >95.00% | |
A cyclotetrapeptide fungal metabolite | ||||
| GC43825 | Histone H1-derived Peptide (trifluoroacetate salt) | - | >95.00% | |
A peptide substrate for CRK3/CYC6 | ||||
| GC43883 | Hymeglusin | 29066-42-0 | >95.00% | |
An HMG-CoA synthase inhibitor | ||||
| GC43893 | iKIX1 | 656222-54-7 | >99.00% | |
An inhibitor of Mediator/Pdr1 interactions | ||||
| GC43894 | IKK2 Inhibitor VI | 354811-10-2 | >95.00% | |
An inhibitor of IKK2 | ||||
| GC43923 | Ivermectin B1a aglycone | 73162-95-5 | >99.00% | |
A macrolide anthelmintic | ||||
| GC43924 | Ivermectin B1a monosaccharide | 71837-27-9 | >99.00% | |
A macrolide anthelmintic | ||||
| GC43927 | JBIR-15 | 1198588-57-6 | >95.00% | |
JBIR-15 是一种新的天冬青素衍生物。 | ||||
| GC43995 | Kazusamycin B | 107140-30-7 | >95.00% | |
A bacterial metabolite | ||||
| GC44004 | Kijanimicin | 78798-08-0 | >99.00% | |
An broad spectrum antibiotic | ||||
| GC44005 | KIN1400 | 446826-86-4 | >98.00% | |
An activator of the RLR pathway | ||||
| GC44020 | L-681,217 | - | >95.00% | |
An antibiotic | ||||
| GC44034 | Lariatin A | 732286-09-8 | >95.00% | |
An antimycobacterial peptide | ||||
| GC44050 | Leucinostatin A | 76600-38-9 | >95.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC44051 | Leucomycin A13 | 78897-52-6 | >99.00% | |
A macrolide antibiotic | ||||
| GC44066 | Lincomycin | 154-21-2 | >98.00% | |
A lincosamide antibiotic | ||||
| GC44078 | LL-37 amide (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC44098 | Lydicamycin | 133352-27-9 | >95.00% | |
An antibiotic effective against MRSA | ||||
| GC44101 | Lyso-Globotriaosylceramide (d18:1) | 126550-86-5 | >98.00% | |
A globotriaosylceramide lacking the fatty acyl group | ||||
| GC44106 | Lythridine | 15299-77-1 | >98.00% | |
A biphenyl quinolizidine lactone alkaloid | ||||
| GC44126 | Manzamine A | 104196-68-1 | >98.00% | |
A β-carboline alkaloid | ||||
| GC44127 | Marcfortine A | 75731-43-0 | >99.00% | |
An anthelmintic | ||||
| GC44138 | MCTR1 | 1784701-61-6 | ≥95% | |
A specialized pro-resolving mediator | ||||
| GC44139 | MCTR2 | 1784701-62-7 | >97.00% | |
A specialized pro-resolving mediator | ||||